Zura Bio (ZURA) News Today $2.22 -0.06 (-2.63%) (As of 10:27 AM ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 Time Period Leerink Partnrs Predicts Increased Earnings for Zura BioDecember 15, 2024 | americanbankingnews.comLeerink Partnrs Forecasts Stronger Earnings for Zura BioZura Bio Limited (NASDAQ:ZURA - Free Report) - Equities researchers at Leerink Partnrs lifted their FY2025 earnings per share (EPS) estimates for shares of Zura Bio in a research note issued on Wednesday, December 11th. Leerink Partnrs analyst F. Khurshid now anticipates that the company will posDecember 13, 2024 | marketbeat.comZura Bio (NASDAQ:ZURA) Earns Overweight Rating from Cantor FitzgeraldDecember 13, 2024 | americanbankingnews.comZura Bio Limited (NASDAQ:ZURA) Receives Average Rating of "Buy" from BrokeragesShares of Zura Bio Limited (NASDAQ:ZURA - Get Free Report) have been given an average recommendation of "Buy" by the seven analysts that are currently covering the firm, MarketBeat reports. One research analyst has rated the stock with a hold recommendation, five have issued a buy recommendationNovember 30, 2024 | marketbeat.comBraidwell LP Buys New Position in Zura Bio Limited (NASDAQ:ZURA)Braidwell LP bought a new stake in Zura Bio Limited (NASDAQ:ZURA - Free Report) in the 3rd quarter, according to its most recent disclosure with the SEC. The fund bought 2,472,806 shares of the company's stock, valued at approximately $10,040,000. Braidwell LP owned approximately 3.68% of Zura BioNovember 29, 2024 | marketbeat.comZura Bio Limited (NASDAQ:ZURA) Director Sells $2,734,458.09 in StockNovember 28, 2024 | insidertrades.comZura Bio Limited (NASDAQ:ZURA) Short Interest UpdateZura Bio Limited (NASDAQ:ZURA - Get Free Report) saw a large growth in short interest during the month of November. As of November 15th, there was short interest totalling 4,960,000 shares, a growth of 183.4% from the October 31st total of 1,750,000 shares. Currently, 10.6% of the shares of the company are sold short. Based on an average trading volume of 444,500 shares, the short-interest ratio is currently 11.2 days.November 28, 2024 | marketbeat.comZura Bio Limited (NASDAQ:ZURA) is Great Point Partners LLC's 10th Largest PositionGreat Point Partners LLC trimmed its position in Zura Bio Limited (NASDAQ:ZURA - Free Report) by 29.7% during the third quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 3,263,672 shares of the company's stock after selling 1November 27, 2024 | marketbeat.comZura Bio to Present at the Piper Sandler 36th Annual Healthcare ConferenceNovember 25, 2024 | businesswire.comHC Wainwright Reaffirms "Neutral" Rating for Zura Bio (NASDAQ:ZURA)HC Wainwright reissued a "neutral" rating and set a $5.00 target price on shares of Zura Bio in a report on Monday.November 18, 2024 | marketbeat.comZura Bio submits protocol to FDA for Phase 2 study of TibulizumabNovember 15, 2024 | markets.businessinsider.comZura Bio Announces Submission of Protocol to U.S. Food and Drug Administration for the Phase 2 Study of Tibulizumab in Adults with Systemic SclerosisNovember 14, 2024 | businesswire.comQ3 Earnings Forecast for Zura Bio Issued By HC WainwrightZura Bio Limited (NASDAQ:ZURA - Free Report) - Research analysts at HC Wainwright raised their Q3 2025 earnings per share estimates for Zura Bio in a report released on Monday, November 11th. HC Wainwright analyst M. Kapoor now anticipates that the company will post earnings of ($0.23) per shareNovember 13, 2024 | marketbeat.comZura Bio's (ZURA) Neutral Rating Reaffirmed at HC WainwrightHC Wainwright restated a "neutral" rating and set a $5.00 target price on shares of Zura Bio in a research note on Monday.November 11, 2024 | marketbeat.comChardan Capital Has Lowered Expectations for Zura Bio (NASDAQ:ZURA) Stock PriceChardan Capital reduced their price target on Zura Bio from $14.00 to $12.00 and set a "buy" rating for the company in a research report on Friday.November 11, 2024 | marketbeat.comZura Bio Limited: Q3 2024 Financial Insights and Strategic ProgressNovember 8, 2024 | markets.businessinsider.comZura Bio Reports Third Quarter 2024 Financial Results and Recent Corporate UpdatesNovember 7, 2024 | businesswire.comQ3 Earnings Forecast for Zura Bio Issued By Leerink PartnrsZura Bio Limited (NASDAQ:ZURA - Free Report) - Analysts at Leerink Partnrs issued their Q3 2024 earnings per share estimates for shares of Zura Bio in a report released on Monday, November 4th. Leerink Partnrs analyst F. Khurshid anticipates that the company will earn ($0.14) per share for the quNovember 6, 2024 | marketbeat.comZura Bio Limited (NASDAQ:ZURA) Receives Average Rating of "Moderate Buy" from BrokeragesZura Bio Limited (NASDAQ:ZURA - Get Free Report) has earned a consensus recommendation of "Moderate Buy" from the five analysts that are currently covering the company, Marketbeat.com reports. One investment analyst has rated the stock with a hold rating and four have issued a buy rating on theNovember 5, 2024 | marketbeat.comZura Bio (NASDAQ:ZURA) Rating Increased to Strong-Buy at Leerink PartnrsLeerink Partnrs raised Zura Bio to a "strong-buy" rating in a report on Monday.November 5, 2024 | marketbeat.comZura Bio initiated with an Outperform at LeerinkNovember 5, 2024 | markets.businessinsider.comLeerink Partners Initiates Coverage of Zura Bio (ZURA) with Outperform RecommendationNovember 5, 2024 | msn.comZura Bio’s Strategic Positioning and Promising Asset Portfolio: A Buy Recommendation by Analyst Faisal KhurshidNovember 5, 2024 | markets.businessinsider.comLeerink Partners Begins Coverage on Zura Bio (NASDAQ:ZURA)Leerink Partners began coverage on shares of Zura Bio in a research report on Monday. They set an "outperform" rating and a $15.00 price target on the stock.November 4, 2024 | marketbeat.comZura Bio to Participate in Two Upcoming Investor Conferences in NovemberOctober 30, 2024 | businesswire.comZura Bio (NASDAQ:ZURA) Stock, Short Interest ReportOctober 29, 2024 | benzinga.comZura Bio (NASDAQ:ZURA) Stock Quotes, Forecast and News SummaryOctober 29, 2024 | benzinga.comAnalysts’ Opinions Are Mixed on These Healthcare Stocks: Universal Health (UHS), Apellis Pharmaceuticals (APLS) and Zura Bio (ZURA)October 29, 2024 | markets.businessinsider.comZura Bio’s Leadership Instability and Uncertain Prospects Lead to Hold RatingOctober 23, 2024 | markets.businessinsider.comZura Bio's (ZURA) "Neutral" Rating Reaffirmed at HC WainwrightHC Wainwright reissued a "neutral" rating and issued a $5.00 target price on shares of Zura Bio in a research note on Monday.October 21, 2024 | marketbeat.comNodenza Venture Partners launched - focus on international early-stage and pre-commercial biotech & medtech opportunitiesOctober 17, 2024 | markets.businessinsider.comBullish Zura Bio Insiders Loaded Up On US$1.01m Of StockOctober 17, 2024 | finance.yahoo.comZura Bio Limited (NASDAQ:ZURA) Sees Significant Growth in Short InterestZura Bio Limited (NASDAQ:ZURA - Get Free Report) saw a large growth in short interest in the month of September. As of September 30th, there was short interest totalling 1,860,000 shares, a growth of 118.9% from the September 15th total of 849,700 shares. Approximately 4.4% of the shares of the company are sold short. Based on an average trading volume of 473,800 shares, the short-interest ratio is currently 3.9 days.October 11, 2024 | marketbeat.comPoint72 Asset Management L.P. Makes New Investment in Zura Bio Limited (NASDAQ:ZURA)Point72 Asset Management L.P. purchased a new stake in shares of Zura Bio Limited (NASDAQ:ZURA - Free Report) in the 2nd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm purchased 2,413,127 shares of the company's stock, valued at approximatelOctober 2, 2024 | marketbeat.comZura Bio Limited (NASDAQ:ZURA) Sees Large Increase in Short InterestZura Bio Limited (NASDAQ:ZURA - Get Free Report) saw a large growth in short interest during the month of September. As of September 15th, there was short interest totalling 849,700 shares, a growth of 28.1% from the August 31st total of 663,300 shares. Based on an average daily volume of 471,000 shares, the short-interest ratio is presently 1.8 days. Approximately 2.0% of the company's shares are short sold.September 27, 2024 | marketbeat.comArmistice Capital LLC Buys 876,000 Shares of Zura Bio Limited (NASDAQ:ZURA)Armistice Capital LLC raised its stake in Zura Bio Limited (NASDAQ:ZURA - Free Report) by 53.2% during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 2,524,000 shares of the company's stock afterSeptember 26, 2024 | marketbeat.comZura Bio Limited (NASDAQ:ZURA) Shares Sold by Affinity Asset Advisors LLCAffinity Asset Advisors LLC trimmed its stake in shares of Zura Bio Limited (NASDAQ:ZURA - Free Report) by 50.4% during the second quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 223,335 shares of the company's stock after selling 226,674 shaSeptember 25, 2024 | marketbeat.comAthanor Capital, LP Adjusts Stake in Zura Bio LtdSeptember 24, 2024 | finance.yahoo.comGreat Point Partners LLC Purchases 1,884,501 Shares of Zura Bio Limited (NASDAQ:ZURA)Great Point Partners LLC increased its holdings in Zura Bio Limited (NASDAQ:ZURA - Free Report) by 68.3% during the second quarter, according to its most recent disclosure with the SEC. The institutional investor owned 4,642,241 shares of the company's stock after buying an additional 1,884,501 shSeptember 24, 2024 | marketbeat.comInstitutions profited after Zura Bio Limited's (NASDAQ:ZURA) market cap rose US$45m last week but private equity firms profited the mostSeptember 20, 2024 | finance.yahoo.comZura Bio (NASDAQ:ZURA) Receives "Overweight" Rating from Piper SandlerPiper Sandler reaffirmed an "overweight" rating and issued a $26.00 target price on shares of Zura Bio in a research note on Thursday.September 19, 2024 | marketbeat.comZura Bio Limited (NASDAQ:ZURA) Sees Significant Drop in Short InterestZura Bio Limited (NASDAQ:ZURA - Get Free Report) was the target of a significant decline in short interest in August. As of August 31st, there was short interest totalling 663,300 shares, a decline of 83.5% from the August 15th total of 4,020,000 shares. Based on an average daily volume of 318,200 shares, the short-interest ratio is currently 2.1 days. Currently, 2.0% of the shares of the stock are short sold.September 12, 2024 | marketbeat.comZura Bio Limited (NASDAQ:ZURA) Expected to Earn Q3 2024 Earnings of ($0.18) Per ShareZura Bio Limited (NASDAQ:ZURA - Free Report) - Research analysts at HC Wainwright issued their Q3 2024 EPS estimates for shares of Zura Bio in a report issued on Thursday, September 5th. HC Wainwright analyst M. Kapoor expects that the company will post earnings per share of ($0.18) for the quartSeptember 9, 2024 | marketbeat.comSomeit Sidhu Sells 51,728 Shares of Zura Bio Limited (NASDAQ:ZURA) StockSeptember 7, 2024 | insidertrades.comZura Bio Limited (NASDAQ:ZURA) Director Sells $200,187.36 in StockZura Bio Limited (NASDAQ:ZURA - Get Free Report) Director Someit Sidhu sold 51,728 shares of the firm's stock in a transaction on Wednesday, September 4th. The stock was sold at an average price of $3.87, for a total value of $200,187.36. Following the completion of the transaction, the director now directly owns 2,085,418 shares of the company's stock, valued at $8,070,567.66. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website.September 6, 2024 | marketbeat.comHC Wainwright & Co. Initiates Coverage of Zura Bio (ZURA) with Neutral RecommendationSeptember 6, 2024 | msn.comZura Bio (NASDAQ:ZURA) Receives New Coverage from Analysts at HC WainwrightHC Wainwright assumed coverage on shares of Zura Bio in a research report on Thursday. They issued a "neutral" rating and a $5.00 price target on the stock.September 5, 2024 | marketbeat.comZura Bio to Present at Three Upcoming Investor Conferences in SeptemberSeptember 3, 2024 | finance.yahoo.comFY2024 EPS Estimates for Zura Bio Limited (NASDAQ:ZURA) Decreased by AnalystZura Bio Limited (NASDAQ:ZURA - Free Report) - Stock analysts at Chardan Capital reduced their FY2024 EPS estimates for Zura Bio in a research report issued on Tuesday, August 13th. Chardan Capital analyst D. Gataulin now forecasts that the company will post earnings per share of ($0.80) for theAugust 16, 2024 | marketbeat.comZura Bio Reports Second Quarter 2024 Financial Results and Recent Business HighlightsAugust 15, 2024 | finance.yahoo.com Get Zura Bio News Delivered to You Automatically Sign up to receive the latest news and ratings for ZURA and its competitors with MarketBeat's FREE daily newsletter. Email Address Cackling Kamala hates this company (Ad)Do you want to see one of the most exciting election trades of all time? A trade that could help America become 100% energy independent… Reduce energy costs to virtually zero… And hand investors what could be a stunning return in just a few years’ time? It all has to do with a little known company that is helping to kick off the next great American energy revolution. Before that happens, you need to see the details here. ZURA Media Mentions By Week ZURA Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ZURA News Sentiment▼0.810.60▲Average Medical News Sentiment ZURA News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ZURA Articles This Week▼02▲ZURA Articles Average Week Get Zura Bio News Delivered to You Automatically Sign up to receive the latest news and ratings for ZURA and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies STOK News CRGX News ALT News EXAI News TERN News ORIC News PHAT News TRML News DNA News PROK News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ZURA) was last updated on 12/23/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredVideo: Blindfolded Man Gets Into a Cybertruck… What Happens Next Will Shock You“Hi, I’m Jeff Brown… Even though I can’t see a thing… I’m about to get in this Cybertruck and drive up t...Brownstone Research | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Zura Bio Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Zura Bio With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
